Paresh N. Soni - Concepedia

Author

Paresh N. Soni

Amarin (United States)

Also Known As

Paresh N Soni, Paresh N. Soni, Paresh Soni

Publications

Citations

H-Index

Concepts

All Affiliations

Amarin (United States)Baylor College of Medicine Louisville Metabolic and Atherosclerosis Research Center Houston Methodist Amsterdam UMC Location University of Amsterdam

About

Paresh N. Soni is an author at Amarin (United States) specializing in medicine, metabolic syndrome, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	819
2	Health Sciences	2	2	144
3	Diabetes	1	1	345
4	Epidemiology	1	1	29
5	Gastroenterology	1	1	68

Paresh N. Soni

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial) Harold Bays, Christie M. Ballantyne, John J.P. Kastelein, The American Journal of Cardiology Metabolic SyndromeLipid DisorderCardiovascular DiseaseMedicineDiabetes	2011	345
Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study) Christie M. Ballantyne, Harold Bays, John J.P. Kastelein, The American Journal of Cardiology Metabolic SyndromeLipid DisorderCardiovascular DiseaseMedicinePersistent High Triglycerides	2012	331
Rationale and design of <scp>REDUCE‐IT</scp>: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Deepak L. Bhatt, Philippe Gabríel Steg, Eliot A. Brinton, Clinical Cardiology	2017	177
Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies Harold Bays, Christie M. Ballantyne, Rene A. Braeckman, American Journal of Cardiovascular Drugs	2013	138
Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study) Harold Bays, Rene A. Braeckman, Christie M. Ballantyne, Journal of clinical lipidology Metabolic SyndromeNutritionOmega-3 Fatty AcidPhysiologyLipoprotein Particle Concentration	2012	91
Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study Eliot A. Brinton, Christie M. Ballantyne, Harold Bays, Cardiovascular Diabetology	2013	70
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study Ulrich Baumann, Ekkehard Sturm, Florence Lacaille, Clinics and Research in Hepatology and Gastroenterology HepatologyBiliary TractLiver PhysiologyPharmacologyPediatrics	2021	68
Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study) Rene A. Braeckman, Mehar S. Manku, Harold Bays, Prostaglandins Leukotrienes and Essential Fatty Acids Lipid AnalysisNutritionMetabolic SyndromeOmega-3 Fatty AcidHigh Triglyceride Levels	2013	53
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies Christie M. Ballantyne, Harold Bays, Sephy Philip, Atherosclerosis	2016	51
Pharmacokinetics of eicosapentaenoic acid in plasma and red blood cells after multiple oral dosing with icosapent ethyl in healthy subjects Rene A. Braeckman, William G. Stirtan, Paresh N. Soni Clinical Pharmacology in Drug Development	2013	50

Page 1